Zobrazeno 1 - 10
of 208
pro vyhledávání: '"John J Friedewald"'
Autor:
Marc Raynaud, PhD, Olivier Aubert, MD, Gillian Divard, MD, Peter P Reese, ProfMD, Nassim Kamar, ProfMD, Daniel Yoo, MPH, Chen-Shan Chin, PhD, Élodie Bailly, MD, Matthias Buchler, ProfMD, Marc Ladrière, ProfMD, Moglie Le Quintrec, ProfMD, Michel Delahousse, ProfMD, Ivana Juric, MD, Nikolina Basic-Jukic, ProfMD, Marta Crespo, ProfMD, Helio Tedesco Silva, Jr, ProfMD, Kamilla Linhares, MD, Maria Cristina Ribeiro de Castro, ProfMD, Gervasio Soler Pujol, ProfMD, Jean-Philippe Empana, ProfMD, Camilo Ulloa, ProfMD, Enver Akalin, ProfMD, Georg Böhmig, ProfMD, Edmund Huang, MD, Mark D Stegall, ProfMD, Andrew J Bentall, ProfMD, Robert A Montgomery, ProfMD, Stanley C Jordan, ProfMD, Rainer Oberbauer, ProfMD, Dorry L Segev, ProfMD, John J Friedewald, ProfMD, Xavier Jouven, ProfMD, Christophe Legendre, ProfMD, Carmen Lefaucheur, ProfMD, Alexandre Loupy, ProfMD
Publikováno v:
The Lancet: Digital Health, Vol 3, Iss 12, Pp e795-e805 (2021)
Summary: Background: Kidney allograft failure is a common cause of end-stage renal disease. We aimed to develop a dynamic artificial intelligence approach to enhance risk stratification for kidney transplant recipients by generating continuously refi
Externí odkaz:
https://doaj.org/article/cb9de491fcba4238b25f7cfc45add677
Autor:
Antoine Bouquegneau, Charlotte Loheac, Olivier Aubert, Yassine Bouatou, Denis Viglietti, Jean-Philippe Empana, Camilo Ulloa, Mohammad Hassan Murad, Christophe Legendre, Denis Glotz, Annette M Jackson, Adriana Zeevi, Stephan Schaub, Jean-Luc Taupin, Elaine F Reed, John J Friedewald, Dolly B Tyan, Caner Süsal, Ron Shapiro, E Steve Woodle, Luis G Hidalgo, Jacqueline O'Leary, Robert A Montgomery, Jon Kobashigawa, Xavier Jouven, Patricia Jabre, Carmen Lefaucheur, Alexandre Loupy
Publikováno v:
PLoS Medicine, Vol 15, Iss 7, p e1002637 (2018)
[This corrects the article DOI: 10.1371/journal.pmed.1002572.].
Externí odkaz:
https://doaj.org/article/ca980d8074d4491384fad726e01c15e7
Autor:
Antoine Bouquegneau, Charlotte Loheac, Olivier Aubert, Yassine Bouatou, Denis Viglietti, Jean-Philippe Empana, Camilo Ulloa, Mohammad Hassan Murad, Christophe Legendre, Denis Glotz, Annette M Jackson, Adriana Zeevi, Stephan Schaub, Jean-Luc Taupin, Elaine F Reed, John J Friedewald, Dolly B Tyan, Caner Süsal, Ron Shapiro, E Steve Woodle, Luis G Hidalgo, Jacqueline O'Leary, Robert A Montgomery, Jon Kobashigawa, Xavier Jouven, Patricia Jabre, Carmen Lefaucheur, Alexandre Loupy
Publikováno v:
PLoS Medicine, Vol 15, Iss 5, p e1002572 (2018)
BACKGROUND:Anti-human leukocyte antigen donor-specific antibodies (anti-HLA DSAs) are recognized as a major barrier to patients' access to organ transplantation and the major cause of graft failure. The capacity of circulating anti-HLA DSAs to activa
Externí odkaz:
https://doaj.org/article/7018c7918ac841e8a4cd19c2e8733c99
Autor:
Laurent Mesnard, Thangamani Muthukumar, Maren Burbach, Carol Li, Huimin Shang, Darshana Dadhania, John R Lee, Vijay K Sharma, Jenny Xiang, Caroline Suberbielle, Maryvonnick Carmagnat, Nacera Ouali, Eric Rondeau, John J Friedewald, Michael M Abecassis, Manikkam Suthanthiran, Fabien Campagne
Publikováno v:
PLoS Computational Biology, Vol 12, Iss 9, p e1005088 (2016)
Current strategies to improve graft outcome following kidney transplantation consider information at the human leukocyte antigen (HLA) loci. Cell surface antigens, in addition to HLA, may serve as the stimuli as well as the targets for the anti-allog
Externí odkaz:
https://doaj.org/article/98500fdb8f4a4c5c929fe66d7e6095d9
Autor:
Sookhyeon Park, Joana Sellares, Claire Tinel, Dany Anglicheau, Oriol Bestard, John J. Friedewald
Publikováno v:
Transplant International, Vol 36 (2024)
To address the need for improved biomarkers for kidney transplant rejection, European Society of Organ Transplantation (ESOT) convened a dedicated working group comprised of experts in kidney transplant biomarkers to review literature pertaining to c
Externí odkaz:
https://doaj.org/article/91e722e2a11e48b4a1acd7fbe371c294
Publikováno v:
Current Opinion in Organ Transplantation. 28:145-148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42f4ad2ea3c74c50a70b961a368925f3
https://doi.org/10.1097/mot.0000000000001049
https://doi.org/10.1097/mot.0000000000001049
Autor:
Sanjay Mehrotra, Juan Marcos Gonzalez, Karolina Schantz, Jui-Chen Yang, John J. Friedewald, Richard Knight
Publikováno v:
Clinical Journal of the American Society of Nephrology. 17:1363-1371
Approximately 20% of deceased donor kidneys are discarded each year in the United States. Some of these kidneys could benefit patients who are waitlisted. Understanding patient preferences regarding accepting marginal-quality kidneys could help more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f5024db7503bb2c37d558fe57152dd
https://doi.org/10.2215/cjn.01480222
https://doi.org/10.2215/cjn.01480222
Publikováno v:
Clinical Journal of the American Society of Nephrology. 17:1353-1362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94294d764b6edf400932eed25c945f5d
https://doi.org/10.2215/cjn.01600222
https://doi.org/10.2215/cjn.01600222
Autor:
Josh Levitsky, John J. Friedewald, Robert J. Fontana, Jenna L. Gustafson, Robert S. Brown, E. Steve Woodle, Meghan E. Sise, Douglas E. Schaubel, Niraj M. Desai, Peter P. Reese, Kenneth E. Sherman, Raymond T. Chung, Ian A. Strohbehn, Emily A. Blumberg, Melissa Fernando, Rita R. Alloway, Christine M. Durand, Meghan Lee, David S. Goldberg, Jens Kort, Samuel Sultan, J. Richard Landis
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 241-250 (2022)
Introduction: Transplanting kidneys from hepatitis C virus (HCV) viremic donors into HCV-negative patients (HCV D-RNA-positive/R-negative) has evolved from experimental to “standard-of-care” at many centers. Nevertheless, most data derive from si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d13d3eaa67c4e52a4b94ead21377af9d
https://doi.org/10.1016/j.ekir.2021.11.022
https://doi.org/10.1016/j.ekir.2021.11.022
Autor:
Stephan Busque, MD, MSc, FRCSC, Flavio G. Vincenti, MD, Helio Tedesco Silva, MD, Philip J. O’Connell, MD, Atsushi Yoshida, MD, John J. Friedewald, MD, Steven M. Steinberg, MD, Klemens Budde, MD, Emine N. Broeders, MD, Yon Su Kim, MD, Carolyn M. Hahn, BA, Huihua Li, MS, Gary Chan, PharmD
Publikováno v:
Transplantation Direct, Vol 4, Iss 9, p e380 (2018)
Background. Tofacitinib is an oral Janus kinase inhibitor. This open-label, long-term extension (LTE) study (NCT00658359) evaluated long-term tofacitinib treatment in stable kidney transplant recipients (n = 178) posttransplant. Methods. Patients who
Externí odkaz:
https://doaj.org/article/b0a113a41fb849ff85e357bd02831398